The DOI matches its Crossref record; 121 of the 121 references it cites were found in a registry or an index.
Molecular and Therapeutic Potential and Toxicity of Valproic Acid
Open accessAbstract
Valproic acid (VPA), a branched short-chain fatty acid, is widely used as an antiepileptic drug and a mood stabilizer. Antiepileptic properties have been attributed to inhibition of Gamma Amino Butyrate (GABA) transaminobutyrate and of ion channels. VPA was recently classified among the Histone Deacetylase Inhibitors, acting directly at the level of gene transcription by inhibiting histone deacetylation and making transcription sites more accessible. VPA is a widely used drug, particularly for children suffering from epilepsy. Due to the increasing number of clinical trials involving VPA, and interesting results obtained, this molecule will be implicated in an increasing number of therapies. However side effects of VPA are substantially described in the literature whereas they are poorly discussed in articles focusing on its therapeutic use. This paper aims to give an overview of the different clinical-trials involving VPA and its side effects encountered during treatment as well as its molecular properties.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Pharmacological interventions for somatoform disorders in adults
Kleinstäuber, M., Witthöft, M., Steffanowski, A., van Marwijk, H., Hiller, W., & Lambert, M. J. (2014) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd010628.pub2 · Cited by 11,335
Histone deacetylase inhibitors and the promise of epigenetic (and more) treatments for cancer
Minucci, S., & Pelicci, P. G. (2006) · Nature Reviews Cancer · doi:10.1038/nrc1779 · Cited by 2,200
Histone Deacetylase Inhibitors: Inducers of Differentiation or Apoptosis of Transformed Cells
Marks, P. A., Richon, V. M., & Rifkind, R. A. (2000) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/92.15.1210 · Cited by 1,157
Correlation between severity and SMN protein level in spinal muscular atrophy
Lefebvre, S., Burlet, P., Liu, Q., Bertrandy, S., Clermont, O., Munnich, A., Dreyfuss, G., & Melki, J. (1997) · Nature Genetics · doi:10.1038/ng0797-265 · Cited by 1,100
Cognitive Function at 3 Years of Age after Fetal Exposure to Antiepileptic Drugs
Meador, K. J., Baker, G. A., Browning, N., Clayton-Smith, J., Combs-Cantrell, D. T., Cohen, M., Kalayjian, L. A., Kanner, A., Liporace, J. D., Pennell, P. B., et al. (2009) · New England Journal of Medicine · doi:10.1056/nejmoa0803531 · Cited by 812
A mammalian protein with specific demethylase activity for mCpG DNA
Bhattacharya, S. K., Ramchandani, S., Cervoni, N., & Szyf, M. (1999) · Nature · doi:10.1038/17533 · Cited by 620
Valproic acid in pregnancy: how much are we endangering the embryo and fetus?
Ornoy, A. (2009) · Reproductive Toxicology · doi:10.1016/j.reprotox.2009.02.014 · Cited by 526
Depletion of latent HIV-1 infection in vivo: a proof-of-concept study
Lehrman, G., Hogue, I. B., Palmer, S., Jennings, C., Spina, C. A., Wiegand, A., Landay, A. L., Coombs, R. W., Richman, D. D., Mellors, J. W., et al. (2005) · The Lancet · doi:10.1016/s0140-6736(05)67098-5 · Cited by 510
Valproic acid hepatic fatalities: A retrospective review
Dreifuss, F. E., Santilli, N., Langer, D. H., Sweeney, K. P., Moline, K. A., & Menander, K. B. (1987) · Neurology · doi:10.1212/wnl.37.3.379 · Cited by 483
(2003) · PubMed · Cited by 465
The Mood‐Stabilizing Agent Valproate Inhibits the Activity of Glycogen Synthase Kinase‐3
Chen, G., Huang, L., Jiang, Y., & Manji, H. K. (2000) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.2000.0721327.x · Cited by 438
Neuropsychological effects of epilepsy and antiepileptic drugs
Kwan, P., & Brodie, M. J. (2001) · The Lancet · doi:10.1016/s0140-6736(00)03600-x · Cited by 434
Bradbury, C. A., Khanim, F. L., Hayden, R., Bunce, C. M., White, D. A., Drayson, M. T., Craddock, C., & Turner, B. M. (2005) · Leukemia · doi:10.1038/sj.leu.2403910 · Cited by 404
Soriano, A. O., Yang, H., Faderl, S., Estrov, Z., Giles, F., Ravandi, F., Cortes, J., Wierda, W. G., Ouzounian, S., Quezada, A., et al. (2007) · Blood · doi:10.1182/blood-2007-03-078576 · Cited by 390
Armeanu, S., Bitzer, M., Lauer, U. M., Venturelli, S., Pathil, A., Krusch, M., Kaiser, S., Jobst, J., Smirnow, I., Wagner, A., et al. (2005) · Cancer Research · doi:10.1158/0008-5472.can-04-4252 · Cited by 358
Duenas-Gonzalez, A., Candelaria, M., Perez-Plascencia, C., Perez-Cardenas, E., de la Cruz-Hernandez, E., & Herrera, L. A. (2008) · Cancer Treatment Reviews · doi:10.1016/j.ctrv.2007.11.003 · Cited by 354
Chen, P.-S., Peng, G.-S., Li, G., Yang, S., Wu, X., Wang, C.-C., Wilson, B., Lu, R.-B., Gean, P.-W., Chuang, D.-M., et al. (2006) · Molecular Psychiatry · doi:10.1038/sj.mp.4001893 · Cited by 351
DNA methylation is a reversible biological signal
Ramchandani, S., Bhattacharya, S. K., Cervoni, N., & Szyf, M. (1999) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.96.11.6107 · Cited by 340
Valproic acid hepatic fatalities. III. U.S. experience since 1986
Bryant, A. E., & Dreifuss, F. E. (1996) · Neurology · doi:10.1212/wnl.46.2.465 · Cited by 339
Histone deacetylase inhibitors in cancer treatment
Vigushin, D. M., & Coombes, R. C. (2002) · Anti-Cancer Drugs · doi:10.1097/00001813-200201000-00001 · Cited by 301
Demethylase Activity Is Directed by Histone Acetylation
Cervoni, N., & Szyf, M. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m103921200 · Cited by 293
Comparison and predictors of rash associated with 15 antiepileptic drugs
Arif, H., Buchsbaum, R., Weintraub, D., Koyfman, S., Salas-Humara, C., Bazil, C. W., Resor, S. R., & Hirsch, L. J. (2007) · Neurology · doi:10.1212/01.wnl.0000261917.83337.db · Cited by 277
Levi, N., Bastuji-Garin, S., Mockenhaupt, M., Roujeau, J.-C., Flahault, A., Kelly, J. P., Martin, E., Kaufman, D. W., & Maison, P. (2009) · Pediatrics · doi:10.1542/peds.2008-1923 · Cited by 270
Chen, P. S., Wang, C.-C., Bortner, C. D., Peng, G.-S., Wu, X., Pang, H., Lu, R.-B., Gean, P.-W., Chuang, D.-M., & Hong, J.-S. (2007) · Neuroscience · doi:10.1016/j.neuroscience.2007.06.053 · Cited by 262
Kuendgen, A., Strupp, C., Aivado, M., Bernhardt, A., Hildebrandt, B., Haas, R., Germing, U., & Gattermann, N. (2004) · Blood · doi:10.1182/blood-2003-12-4333 · Cited by 255
[Pharmacodynamic properties of N-dipropylacetic acid].
Meunier, H., Carraz, G., Neunier, Y., Eymard, P., & Aimard, M. (1963) · PubMed · Cited by 251
Lamotrigine Clinical Pharmacokinetics
Rambeck, B., & Wolf, P. (1993) · Clinical Pharmacokinetics · doi:10.2165/00003088-199325060-00003 · Cited by 244
Kuendgen, A., Schmid, M., Schlenk, R., Knipp, S., Hildebrandt, B., Steidl, C., Germing, U., Haas, R., Dohner, H., & Gattermann, N. (2006) · Cancer · doi:10.1002/cncr.21552 · Cited by 224
Valproic acid hepatic fatalities.: II. US experience since 1984
Dreifuss, F. E., Langer, D. H., Moline, K. A., & Maxwell, J. E. (1989) · Neurology · doi:10.1212/wnl.39.2.201 · Cited by 219
Valproic Acid Alters Chromatin Structure by Regulation of Chromatin Modulation Proteins
Marchion, D. C., Bicaku, E., Daud, A. I., Sullivan, D. M., & Munster, P. N. (2005) · Cancer Research · doi:10.1158/0008-5472.can-04-2478 · Cited by 212
Cross-talk between Histone Modifications in Response to Histone Deacetylase Inhibitors
Nightingale, K. P., Gendreizig, S., White, D. A., Bradbury, C., Hollfelder, F., & Turner, B. M. (2007) · Journal of Biological Chemistry · doi:10.1074/jbc.m606773200 · Cited by 191
Bug, G., Ritter, M., Wassmann, B., Schoch, C., Heinzel, T., Schwarz, K., Romanski, A., Kramer, O. H., Kampfmann, M., Hoelzer, D., et al. (2005) · Cancer · doi:10.1002/cncr.21589 · Cited by 184
Atmaca, A., Al-Batran, S.-E., Maurer, A., Neumann, A., Heinzel, T., Hentsch, B., Schwarz, S. E., Hövelmann, S., Göttlicher, M., Knuth, A., et al. (2007) · British Journal of Cancer · doi:10.1038/sj.bjc.6603851 · Cited by 183
Phase II Open Label Study of Valproic Acid in Spinal Muscular Atrophy
Swoboda, K. J., Scott, C. B., Reyna, S. P., Prior, T. W., LaSalle, B., Sorenson, S. L., Wood, J., Acsadi, G., Crawford, T. O., Kissel, J. T., et al. (2009) · PLoS ONE · doi:10.1371/journal.pone.0005268 · Cited by 176
Monti, B., Gatta, V., Piretti, F., Raffaelli, S. S., Virgili, M., & Contestabile, A. (2010) · Neurotoxicity Research · doi:10.1007/s12640-009-9090-5 · Cited by 175
Cervoni, N., Detich, N., Seo, S.-B., Chakravarti, D., & Szyf, M. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m202256200 · Cited by 175
Clayton-Smith, J., & Donnai, D. (1995) · Journal of Medical Genetics · doi:10.1136/jmg.32.9.724 · Cited by 164
Sensitization, kindling, and anticonvulsants in mania.
Sl, M., Keck, P. E., Pope, H. G., & Hudson, J. I. (1989) · PubMed · Cited by 162
Münster, P. N., Marchion, D. C., Biçaku, E., Lacevic, M., Kim, J., Centeno, B. A., DAUD, A. I., Neuger, A. M., Minton, S. E., & Sullivan, D. M. (2009) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-08-1930 · Cited by 160
Prolonged valproic acid treatment does not reduce the size of latent HIV reservoir
Lerolle, N., Lamine, A., Chaix, M., Boufassa, F., Aboulker, J.-P., Costagliola, D. G., Goujard, C., Paller, C., Delfraissy, J., & Lambotte, O. (2008) · AIDS · doi:10.1097/qad.0b013e3282fd6ddc · Cited by 158
Woyach, J. A., Kloos, R. T., Ringel, M. D., Arbogast, D., Collamore, M., Zwiebel, J. A., Grever, M. R., Villalona-Calero, M. A., & Shah, M. H. (2008) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2008-1631 · Cited by 156
Valproate preparations for agitation in dementia
Lonergan, E., & Luxenberg, J. S. (2009) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd003945.pub3 · Cited by 155
Kuendgen, A., Knipp, S., Fox, F., Strupp, C., Hildebrandt, B., Steidl, C., Germing, U., Haas, R. R., & Gattermann, N. (2005) · Annals of Hematology · doi:10.1007/s00277-005-0026-8 · Cited by 154
Arce, C., Pérez‐Plasencia, C., González‐Fierro, A., la Cruz-Hernández, E. N. D., Vázquez, A. L. R., Chávez-Blanco, A. D., Trejo‐Becerril, C., Pérez‐Cárdenas, E., Taja‐Chayeb, L., Bargalló, E., et al. (2006) · PLoS ONE · doi:10.1371/journal.pone.0000098 · Cited by 146
Chávez-Blanco, A. D., Pérez‐Plasencia, C., Pérez‐Cárdenas, E., Legleu, C. E. C., Rangel‐López, E., Segura-Pacheco, B. A., Taja‐Chayeb, L., Trejo‐Becerril, C., González‐Fierro, A., Candelaria, M., et al. (2006) · Cancer Cell International · doi:10.1186/1475-2867-6-2 · Cited by 143
Valproate for the treatment of acute bipolar depression: Systematic review and meta-analysis
Smith, L. A., Cornelius, V. R., Azorin, J., Perugi, G., Vieta, E., Young, A. H., & Bowden, C. L. (2009) · Journal of Affective Disorders · doi:10.1016/j.jad.2009.10.033 · Cited by 140
Zeise, M. L., Kasparow, S., & Zieglgänsberger, W. (1991) · Brain Research · doi:10.1016/0006-8993(91)90078-a · Cited by 139
Randomized sequential trial of valproic acid in amyotrophic lateral sclerosis
Piepers, S., Veldink, J. H., de Jong, S. W., van der Tweel, I., van der Pol, W. L., Uijtendaal, E. V., Schelhaas, H. J., Scheffer, H., de Visser, M., de Jong, J. M. B. V., et al. (2009) · Annals of Neurology · doi:10.1002/ana.21620 · Cited by 137
Valproate Reduces Excitability by Blockage of Sodium and Potassium Conductance
VanDongen, A. M. J., VanErp, M. G., & Voskuyl, R. A. (1986) · Epilepsia · doi:10.1111/j.1528-1157.1986.tb03525.x · Cited by 137
Valproic Acid Induces Apoptosis and Cell Cycle Arrest in Poorly Differentiated Thyroid Cancer Cells
Catalano, M. G., Fortunati, N., Pugliese, M., Costantino, L., Poli, R., Bosco, O., & Boccuzzi, G. (2005) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2004-1355 · Cited by 137
Marinova, Z., Ren, M., Wendland, J. R., Leng, Y., Liang, M., Yasuda, S., Leeds, P. R., & Chuang, D. (2009) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2009.06385.x · Cited by 132
Histone deacetylases as therapeutic targets in hematologic malignancies
Melnick, A. M., & Licht, J. D. (2002) · Current Opinion in Hematology · doi:10.1097/00062752-200207000-00010 · Cited by 132
Valproate‐associated Coagulopathies Are Frequent and Variable in Children
Gerstner, T. A., Teich, M., Bell, N. V. T., Longin, E., Dempfle, C.-E. H., Brand, J., & König, S. (2006) · Epilepsia · doi:10.1111/j.1528-1167.2006.00587.x · Cited by 130
Pathil, A., Armeanu, S., Venturelli, S., Mascagni, P., Weiß, T. S., Gregor, M., Lauer, U. M., & Bitzer, M. (2006) · Hepatology · doi:10.1002/hep.21054 · Cited by 126
Chronic Administration of Valproic Acid Inhibits Prostate Cancer Cell Growth In vitro and In vivo
Xia, Q., Sung, J., Chowdhury, W. H., Chen, C., Höti, N., Shabbeer, S., Carducci, M. A., & Rodríguez, R. (2006) · Cancer Research · doi:10.1158/0008-5472.can-05-0487 · Cited by 123
Clinical Pharmacokinetics of Antiepileptic Drugs in Paediatric Patients
Battino, D., Estienne, M., & AVANZINI, G. (1995) · Clinical Pharmacokinetics · doi:10.2165/00003088-199529040-00005 · Cited by 121
Voso, M. T., Santini, V., Finelli, C., Musto, P., Pogliani, E., Angelucci, E., Fioritoni, G., Alimena, G., Maurillo, L., Cortelezzi, A., et al. (2009) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-09-0494 · Cited by 113
Antiepileptic drug use in women of childbearing age
Meador, K. J., Penovich, P. E., Baker, G. A., Pennell, P. B., Bromfield, E. B., Pack, A. M., Liporace, J. D., Sam, M. C., Kalayjian, L. A., Thurman, D. J., et al. (2009) · Epilepsy & Behavior · doi:10.1016/j.yebeh.2009.04.026 · Cited by 111
Identification of novel direct Stat3 target genes for control of growth and differentiation
Snyder, M., Huang, X.-Y., & Zhang, J. J. (2008) · Journal of Biological Chemistry · doi:10.1074/jbc.m706976200 · Cited by 108 · cited 1×
“This inhibition led to a decrease in the dimerisation of STAT3 and its translocation into the nucleus for transcriptional activation of many genes in a wide range of biological processes, including induction of immune response, oncogenesis, cell cycle control, development, cell adhesion, and differentiation [63].”
BackgroundHodges-Gallagher, L., Valentine, C. D., Bader, S. E., & Kushner, P. J. (2006) · Breast Cancer Research and Treatment · doi:10.1007/s10549-006-9459-6 · Cited by 108
Serum Concentrations of Lamotrigine in Epileptic Patients: The Influence of Dose and Comedication
May, T. W., Rambeck, B., & Jürgens, U. H. (1996) · Therapeutic Drug Monitoring · doi:10.1097/00007691-199610000-00001 · Cited by 105
Kassahun, K., Farrell, K., & Abbott, F. S. (1991) · Drug Metabolism and Disposition · doi:10.1016/s0090-9556(25)07155-7 · Cited by 104
Das, C. M., Aguilera, D. G., Vasquez, H., Prasad, P., Zhang, M., Wolff, J. E. A., & Gopalakrishnan, V. (2007) · Journal of Neuro-Oncology · doi:10.1007/s11060-007-9402-7 · Cited by 102
Gean, P., Huang, C., Hung, C., & Tsai, J.-J. (1994) · Brain Research Bulletin · doi:10.1016/0361-9230(94)90202-x · Cited by 102
Gerstner, T. A., Büsing, D., Longin, E., Bendl, C., Wenzel, D., Scheid, B., Goetze, G., Macke, A., Lippert, G., Klostermann, W., et al. (2006) · Seizure · doi:10.1016/j.seizure.2006.05.007 · Cited by 102
Zádori, D., Geisz, A., Vámos, E., Vécsei, L., & Klivènyi, P. (2009) · Pharmacology Biochemistry and Behavior · doi:10.1016/j.pbb.2009.08.001 · Cited by 97
Antitumor activity of sodium valproate in cultures of human neuroblastoma cells
Cínatl, J., Činátl, J., Scholz, M., et al. (1996) · Anti-Cancer Drugs · doi:10.1097/00001813-199609000-00008 · Cited by 88
Risk of Aplastic Anemia in Patients Using Antiepileptic Drugs
Handoko, K. B., Souverein, P. C., van Staa, T. P., et al. (2006) · Epilepsia · doi:10.1111/j.1528-1167.2006.00596.x · Cited by 86
DAUD, A. I., Dawson, J. L., DeConti, R. C., Biçaku, E., Marchion, D. C., Bastien, S., Hausheer, F. A., Lush, R. M., Neuger, A. M., Sullivan, D. M., et al. (2009) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-08-1931 · Cited by 86
Mongan, N. P., & Gudas, L. J. (2005) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.mct-04-0079 · Cited by 85
Valproic acid‐mediated Hsp70 induction and anti‐apoptotic neuroprotection in SH‐SY5Y cells
Pan, T., Li, X., Xie, W., Jankovic, J. J., & Le, W. (2005) · FEBS Letters · doi:10.1016/j.febslet.2005.10.067 · Cited by 81
Valproic acid-associated weight gain in older children and teens with epilepsy
Wirrell, E. C. (2003) · Pediatric Neurology · doi:10.1016/s0887-8994(02)00505-2 · Cited by 80
Agrawal, R. P., Goswami, J., Jain, S., & Kochar, D. K. (2009) · Diabetes Research and Clinical Practice · doi:10.1016/j.diabres.2008.12.018 · Cited by 80
Valproic Acid in Epilepsy: Pregnancy-Related Issues
Genton, P., Semah, F., & Trinka, E. (2006) · Drug Safety · doi:10.2165/00002018-200629010-00001 · Cited by 79
Rocca, A., Minucci, S., Tosti, G., Croci, D., Contegno, F., Ballarini, M., Nolè, F., Munzone, E., Salmaggi, A., Goldhirsch, A., et al. (2009) · British Journal of Cancer · doi:10.1038/sj.bjc.6604817 · Cited by 79
Moog, C., Simon, G., Caussin‐Schwemling, C., & Obert, G. (1996) · Journal of General Virology · doi:10.1099/0022-1317-77-9-1993 · Cited by 78
Topiramate Enhances the Risk of Valproate‐associated Side Effects in Three Children
Longin, E., Teich, M., Koelfen, W., & König, S. (2002) · Epilepsia · doi:10.1046/j.1528-1157.2002.42401.x · Cited by 78
Gopaul, S., Farrell, K., & Abbott, F. S. (2003) · Epilepsia · doi:10.1046/j.1528-1157.2003.07202.x · Cited by 77
Schuchmann, M., Schulze‐Bergkamen, H., Fleischer, B., Schattenberg, J. M., Siebler, J., Weinmann, A., Teufel, A., Wörns, M., Fischer, T., Strand, S., et al. (2006) · Oncology Reports · doi:10.3892/or.15.1.227 · Cited by 77
Lagneaux, L., Gillet, N. A., Stamatopoulos, B., Delforge, A., Dejeneffe, M., Massy, M., Meuleman, N., Kentos, A., Martiat, P., Willems, L., et al. (2007) · Experimental Hematology · doi:10.1016/j.exphem.2007.06.014 · Cited by 76
Gurpur, P. B., Liu, J., Burkin, D. J., & Kaufman, S. J. (2009) · American Journal Of Pathology · doi:10.2353/ajpath.2009.080537 · Cited by 75
Impaired methionine synthesis and hypomethylation in rats exposed to valproate during gestation
Alonso-Aperte, E., Úbeda, N., Achón, M., Pérez‐Miguelsanz, J., & Varela‐Moreiras, G. (1999) · Neurology · doi:10.1212/wnl.52.4.750 · Cited by 74
Thelen, P., Schweyer, S., Hemmerlein, B., Wuttke, W., Seseke, F., & Ringert, R.-H. (2004) · International Journal of Oncology · doi:10.3892/ijo.24.1.25 · Cited by 71
GHB (γ-Hydroxybutyrate) Carrier-Mediated Transport across the Blood-Brain Barrier
Bhattacharya, I., & Boje, K. M. K. (2004) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.104.069682 · Cited by 71
Valproic Acid Activates Notch1 Signaling and Induces Apoptosis in Medullary Thyroid Cancer Cells
Greenblatt, D. Y., Cayo, M. A., Adler, J. T., Ning, L., Haymart, M. R., Kunnimalaiyaan, M., & Chen, H. (2008) · Annals of Surgery · doi:10.1097/sla.0b013e3181758d0e · Cited by 70
Alpha‐synuclein protects cerebellar granule neurons against 6‐hydroxydopamine‐induced death
Monti, B., Polazzi, E., Batti, L., Crochemore, C., Virgili, M., & Contestabile, A. (2007) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2007.04778.x · Cited by 68
Martirosyan, A., Leonard, S. S., Shi, X., Griffith, B. N., Gannett, P. M., & Strobl, J. S. (2006) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.105.096891 · Cited by 65
Werling, U., Siehler, S., Litfin, M., Nau, H., & Göttlicher, M. (2001) · Molecular Pharmacology · doi:10.1124/mol.59.5.1269 · Cited by 63
Huang, X., & Guo, B. (2006) · Cancer Research · doi:10.1158/0008-5472.can-06-0887 · Cited by 62
Lampen, A., Siehler, S., Ellerbeck, U., Göttlicher, M., & Nau, H. (1999) · Toxicology and Applied Pharmacology · doi:10.1006/taap.1999.8770 · Cited by 61
Sodium Valproate versus Propranolol in paediatric migraine prophylaxis
Ashrafi, M. R., Shabanian, R., Zamani, G., & Mahfelati, F. (2005) · European Journal of Paediatric Neurology · doi:10.1016/j.ejpn.2005.05.004 · Cited by 61
Serum Concentrations of Valproic Acid
May, T., & Rambeck, B. (1985) · Therapeutic Drug Monitoring · doi:10.1097/00007691-198512000-00004 · Cited by 60
Sodium valproate: Kinetic profile and effects on GABA levels in various brain areas of the rat
Mesdjian, E., Ciesielski, L., Valli, M., et al. (1982) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/s0278-5846(82)80172-3 · Cited by 60
Kaipananickal, H., Karagiannis, T. C., Chow, M. Z. Y., & El‐Osta, A. (2008) · Cell Cycle · doi:10.4161/cc.7.4.5405 · Cited by 57
Anxiety disorders and the use and abuse of drugs.
Calabrese, J. R., & Delucchi, G. A. (1989) · PubMed · Cited by 57
HDAC3 influences phosphorylation of STAT3 at serine 727 by interacting with PP2A
Togi, S., Kamitani, S., Kawakami, S., Ikeda, O., Muromoto, R., Nanbo, A., & Matsuda, T. (2009) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2008.12.132 · Cited by 56
Cheng, Y.-C., Lin, H., Huang, M.-J., Chow, J., Lin, S., & Liu, H. E. (2007) · Leukemia Research · doi:10.1016/j.leukres.2007.03.012 · Cited by 54
Ziauddin, M. F., Yeow, W.-S., Maxhimer, J. B., Baras, A., Chua, A., Reddy, R. M., Tsai, W. S., Cole, G. W., Schrump, D. S., & Nguyen, D. M. (2006) · Neoplasia · doi:10.1593/neo.05823 · Cited by 54
Citrome, L., Shope, C. B., Nolan, K. A., Czobor, P., & Volavka, J. (2007) · International Clinical Psychopharmacology · doi:10.1097/yic.0b013e3281c61baf · Cited by 49
Hardy, J. R., Rees, E., Gwilliam, B., Ling, J., Broadley, K. E., & A’Hern, R. (2001) · Journal of Pain and Symptom Management · doi:10.1016/s0885-3924(00)00266-9 · Cited by 49
Savickienė, J., Borutinskaite, V. V., Treigytė, G., Magnusson, K., & Navakauskienė, R. (2006) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2006.08.010 · Cited by 47
Glick, I. D., Bosch, J., & Casey, D. E. (2009) · Journal of Clinical Psychopharmacology · doi:10.1097/jcp.0b013e3181a443d0 · Cited by 46
Michaelis, M., Suhan, T. O., Činátl, J., Driever, P. H., & Cinatl, J. J. (2004) · International Journal of Oncology · doi:10.3892/ijo.25.6.1795 · Cited by 45
Valproic Acid Inhibits Invasiveness in Bladder Cancer but Not in Prostate Cancer Cells
Chen, C., Sung, J., Cohen, M. J., Chowdhury, W. H., Sachs, M. D., Li, Y., Lakshmanan, Y., Yung, B. Y., Lupold, S. E., & Rodríguez, R. (2006) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.106.106658 · Cited by 45
Witvrouw, M., Schmit, J., Remoortel, B. V., Daelemans, D., Esté, J. A., Vandamme, A., Desmyter, J., & Clercq, E. D. (1997) · AIDS Research and Human Retroviruses · doi:10.1089/aid.1997.13.187 · Cited by 43
Sodium valproate induces apoptosis in the rat hepatoma cell line, FaO
Phillips, A., Bullock, T., & Plant, N. J. (2003) · Toxicology · doi:10.1016/s0300-483x(03)00331-7 · Cited by 41
Effects of valproic acid on sleep in children with epilepsy
Schmitt, B., Martin, F., Critelli, H., Molinari, L., & Jenni, O. G. (2009) · Epilepsia · doi:10.1111/j.1528-1167.2009.02105.x · Cited by 41
Cancer Risk in Long-term Users of Valproate: A Population-Based Case-Control Study
Hallas, J., Friis, S., Bjerrum, L., Støvring, H., Narverud, S. F., Heyerdahl, T., Grønbæk, K., & Andersen, M. T. (2009) · Cancer Epidemiology Biomarkers & Prevention · doi:10.1158/1055-9965.epi-08-0646 · Cited by 39
The emerging role of epigenetic modifications and chromatin remodeling in spinal muscular atrophy
Lunke, S., & El‐Osta, A. (2009) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2009.06084.x · Cited by 37
Grosso, S., Mostardini, R., Piccini, B., et al. (2008) · Annals of Pharmacotherapy · doi:10.1345/aph.1l414 · Cited by 36
Sheorajpanday, R. V. A., & Deyn, P. P. D. (2007) · Clinical Neurology and Neurosurgery · doi:10.1016/j.clineuro.2007.07.002 · Cited by 32
Friedmann, I., Atmaca, A., Chow, K. U., Jäger, E., & Weidmann, E. (2006) · Journal of Chemotherapy · doi:10.1179/joc.2006.18.4.415 · Cited by 25
Lan, M. J., Yuan, P., Chen, G., & Manji, H. K. (2008) · Journal of Molecular Neuroscience · doi:10.1007/s12031-008-9056-8 · Cited by 24
Kristensen, Ø., Lølandsmo, T., Isaksen, Å., Vederhus, J., & Clausen, T. (2006) · BMC Psychiatry · doi:10.1186/1471-244x-6-54 · Cited by 21
Elevated FOSB‐expression; a potential marker of valproate sensitivity in AML
Khanim, F. L., Bradbury, C. A., Arrazi, J., Hayden, R. E., Rye, A., Basu, S., Macwhannell, A., Sawers, A., Griffiths, M., Cook, M. A., et al. (2008) · British Journal of Haematology · doi:10.1111/j.1365-2141.2008.07449.x · Cited by 21
Kieslich, M., Schwabe, D., Cinatl, J. J., et al. (2003) · Pediatric Hematology and Oncology · doi:10.1080/08880010390158496 · Cited by 21
Epileptic disorders in pregnancy: an overview
Harden, C. L., & Sethi, N. K. (2008) · Current Opinion in Obstetrics & Gynecology · doi:10.1097/gco.0b013e3283184059 · Cited by 16
Juvenile Absence Epilepsy Exacerbated by Valproic Acid
Buechler, R. D., & Buchhalter, J. (2007) · Pediatric Neurology · doi:10.1016/j.pediatrneurol.2006.08.011 · Cited by 15
Valproate-induced parkinsonism, glial cells and Alexander's disease
Sechi, G., Conti, M., Sau, G. F., & Cocco, G. A. (2008) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2008.03.022 · Cited by 13
Novick, D., González-Pinto, A. M., Haro, J. M., Bertsch, J., Reed, C. C., Perrin, E., & Tohen, M. F. (2009) · Pharmacopsychiatry · doi:10.1055/s-0028-1128115 · Cited by 9
Varoğlu, A. O. (2009) · Epilepsy Research · doi:10.1016/j.eplepsyres.2009.06.009 · Cited by 9
Cited by
A Quantitative Proteome Map of the Human Body
Jiang, L., Wang, M., Lin, S., Jian, R., Li, X., Chan, J., Dong, G., Fang, H., Robinson, A. E., Aguet, F., et al. (2020) · Cell · doi:10.1016/j.cell.2020.08.036 · Cited by 458
Multi-Organ toxicity demonstration in a functional human in vitro system composed of four organs
Oleaga, C., Bernabini, C., Smith, A. S. T., Srinivasan, B., Jackson, M., McLamb, W., Platt, V., Bridges, R., Cai, Y., Santhanam, N., et al. (2016) · Scientific Reports · doi:10.1038/srep20030 · Cited by 442
Therapeutic potential of mood stabilizers lithium and valproic acid:Beyond bipolar disorder
Chiu, C.-T., Wang, Z., Hunsberger, J. G., & Chuang, D.-M. (2013) · Pharmacological Reviews · doi:10.1124/pr.111.005512 · Cited by 404
Valproic acid pathway: pharmacokinetics and pharmacodynamics
Ghodke-Puranik, Y., Thorn, C. F., Lamba, J. K., Leeder, J. S., Song, W., Birnbaum, A. K., Altman, R. B., & Klein, T. E. (2013) · Pharmacogenetics and Genomics · doi:10.1097/fpc.0b013e32835ea0b2 · Cited by 397
Valproic Acid and Epilepsy: From Molecular Mechanisms to Clinical Evidences
Romoli, M., Mazzocchetti, P., D'Alonzo, R., Siliquini, S., Rinaldi, V. E., Verrotti, A., Calabresi, P., & Costa, C. (2019) · Current Neuropharmacology · doi:10.2174/1570159x17666181227165722 · Cited by 372
Metadata
- Authors
- Chateauvieux, S., Morceau, F., Dicato, M., & Diederich, M.
- Venue
- Journal of Biomedicine and Biotechnology
- Publisher
- Wiley
- Published
- 2010
- Volume
- 2010
- Pages
- 1-18
- ISSN
- 1110-7243 (ISSN-L)
- 1110-7251
- OpenAlex
- W2071934663
- Cited by
- 512
- References
- 121
- FWCI
- 22.31
- Type
- journal article
- Language
- en
- Open access
- hybrid
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.